These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 16712644)

  • 21. A novel multiplex pyrosequencing assay for genotyping functionally relevant CTLA-4 polymorphisms: potential applications in autoimmunity and cancer.
    Banelli B; Morabito A; Laurent S; Piccioli P; Dozin B; Ghio M; Ascierto PA; Monteghirfo S; Marasco A; Ottaviano V; Queirolo P; Romani M; Pistillo MP
    Hum Immunol; 2014 Aug; 75(8):730-9. PubMed ID: 24801647
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interleukin 1alpha single-nucleotide polymorphism associated with systemic sclerosis.
    Hutyrová B; Lukác J; Bosák V; Buc M; du Bois R; Petrek M
    J Rheumatol; 2004 Jan; 31(1):81-4. PubMed ID: 14705223
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transforming growth factor beta1 gene polymorphism in patients with systemic sclerosis.
    Sugiura Y; Banno S; Matsumoto Y; Niimi T; Yoshinouchi T; Hayami Y; Naniwa T; Ueda R
    J Rheumatol; 2003 Jul; 30(7):1520-3. PubMed ID: 12858451
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical correlates of human leucocyte antigen (HLA)-G in systemic sclerosis.
    Favoino E; Favia IE; Vettori S; Vicenti C; Prete M; Valentini G; Perosa F
    Clin Exp Immunol; 2015 Jul; 181(1):100-9. PubMed ID: 25847615
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phenotype-haplotype correlation of IRF5 in systemic sclerosis: role of 2 haplotypes in disease severity.
    Dieude P; Dawidowicz K; Guedj M; Legrain Y; Wipff J; Hachulla E; Diot E; Sibilia J; Mouthon L; Cabane J; Amoura Z; Crakowski JL; Carpentier P; Avouac J; Meyer O; Kahan A; Boileau C; Allanore Y
    J Rheumatol; 2010 May; 37(5):987-92. PubMed ID: 20231204
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The IL-33 gene is related to increased susceptibility to systemic sclerosis.
    Koca SS; Pehlivan Y; Kara M; Alibaz-Oner F; Oztuzcu S; Yilmaz N; Cetin GY; Kisacik B; Ozgen M; Pamuk ON; Direskeneli H; Sayarlioglu M; Onat AM
    Rheumatol Int; 2016 Apr; 36(4):579-84. PubMed ID: 26743213
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polymorphism of immunoglobulin enhancer element HS1,2A: allele *2 associates with systemic sclerosis. Comparison with HLA-DR and DQ allele frequency.
    Frezza D; Giambra V; Tolusso B; De Santis M; Bosello S; Vettori S; Triolo G; Valentini G; Ferraccioli G
    Ann Rheum Dis; 2007 Sep; 66(9):1210-5. PubMed ID: 17392350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CTLA-4 and CD86 genetic variants and haplotypes in patients with rheumatoid arthritis in southeastern China.
    Liu CP; Jiang JA; Wang T; Liu XM; Gao L; Zhu RR; Shen Y; Wu M; Xu T; Zhang XG
    Genet Mol Res; 2013 Apr; 12(2):1373-82. PubMed ID: 23661460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proximal interleukin-10 gene polymorphisms in Italian patients with systemic sclerosis.
    Beretta L; Cappiello F; Barili M; Scorza R
    Tissue Antigens; 2007 Apr; 69(4):305-12. PubMed ID: 17389013
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TLR2, TLR4 and CD86 gene polymorphisms in recurrent aphthous stomatitis.
    Karasneh J; Bani-Hani M; Alkhateeb A; Hassan A; Alzoubi F; Thornhill M
    J Oral Pathol Med; 2015 Nov; 44(10):857-63. PubMed ID: 25482673
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence of potential interaction of chemokine genes in susceptibility to systemic sclerosis.
    Lee EB; Zhao J; Kim JY; Xiong M; Song YW
    Arthritis Rheum; 2007 Jul; 56(7):2443-8. PubMed ID: 17599774
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Macrophage migration inhibitory factor promoter polymorphisms and the clinical expression of scleroderma.
    Wu SP; Leng L; Feng Z; Liu N; Zhao H; McDonald C; Lee A; Arnett FC; Gregersen PK; Mayes MD; Bucala R
    Arthritis Rheum; 2006 Nov; 54(11):3661-9. PubMed ID: 17075815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of a functional polymorphism in the IRF5 region with systemic sclerosis in a Japanese population.
    Ito I; Kawaguchi Y; Kawasaki A; Hasegawa M; Ohashi J; Hikami K; Kawamoto M; Fujimoto M; Takehara K; Sato S; Hara M; Tsuchiya N
    Arthritis Rheum; 2009 Jun; 60(6):1845-50. PubMed ID: 19479858
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of the FAM167A-BLK region with systemic sclerosis.
    Ito I; Kawaguchi Y; Kawasaki A; Hasegawa M; Ohashi J; Kawamoto M; Fujimoto M; Takehara K; Sato S; Hara M; Tsuchiya N
    Arthritis Rheum; 2010 Mar; 62(3):890-5. PubMed ID: 20131239
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lack of association between the protein tyrosine phosphatase non-receptor 22 (PTPN22)*620W allele and systemic sclerosis in the French Caucasian population.
    Wipff J; Allanore Y; Kahan A; Meyer O; Mouthon L; Guillevin L; Pierlot C; Glikmans E; Bardin T; Boileau C; Cornélis F; Dieudé P
    Ann Rheum Dis; 2006 Sep; 65(9):1230-2. PubMed ID: 16464986
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between Thr21Met and Ser89Asn polymorphisms of the urotensin II gene and systemic sclerosis.
    Pehlivan Y; Gogebakan B; Oztuzcu S; Ozgen M; Cetin GY; Bayraktar R; Cengiz B; Kisacik B; Koca SS; Donmez S; Sayarlioglu M; Demiryurek AT; Onat AM
    J Rheumatol; 2012 Jan; 39(1):106-11. PubMed ID: 22045841
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of the PTPN22 R620W polymorphism with anti-topoisomerase I- and anticentromere antibody-positive systemic sclerosis.
    Gourh P; Tan FK; Assassi S; Ahn CW; McNearney TA; Fischbach M; Arnett FC; Mayes MD
    Arthritis Rheum; 2006 Dec; 54(12):3945-53. PubMed ID: 17133608
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between 'interleukin' 10 gene (IL10) polymorphisms and systemic sclerosis with interstitial lung involvement.
    Ates O; Müsellim B; Ongen G; Topal-Sarikaya A
    Rheumatol Int; 2008 Sep; 28(11):1123-6. PubMed ID: 18493769
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ability of epistatic interactions of cytokine single-nucleotide polymorphisms to predict susceptibility to disease subsets in systemic sclerosis patients.
    Beretta L; Cappiello F; Moore JH; Barili M; Greene CS; Scorza R
    Arthritis Rheum; 2008 Jul; 59(7):974-83. PubMed ID: 18576303
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Altered B lymphocyte function induces systemic autoimmunity in systemic sclerosis.
    Sato S; Fujimoto M; Hasegawa M; Takehara K; Tedder TF
    Mol Immunol; 2004 Nov; 41(12):1123-33. PubMed ID: 15482848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.